Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 12/20 | 0.71 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.69 |
| ▸ | HTR1D | P28221 | 3/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.68 |
| ▸ | HRH1 | P35367 | 1/20 | 0.65 |
| ▸ | CNR1 | P21554 | 2/20 | 0.62 |
| ▸ | CNR2 | P34972 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30516171 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL3696854 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL1681954 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL30516172 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL7616127 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL10589534 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL18551586 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL755688 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL20506760 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 | |
| SCHEMBL9483628 | 0.98 | HTR1B (0.69) | HTR1BKCNA3HTR1DSLC6A4HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1149819-B1 | An improved process for acylation of naphthyl ethers | COUNCIL SCIENT IND RES (IN) | 2003-04-16 | — | — | EP | claimed |
| US-6320082-B1 | REACTING NAPHTHYL ETHER WITH ACID ANHYDRIDE EMPLOYING SYNTHESIZED, MICROCRYSTALLINE, OR MICROCRYSTALLINE MODIFIED ZEOLITE BETA CATALYST IN NITROBENZENE AS SOLVENT, RECOVERING ACYL NAPHTHYL ETHERS BY CONVENTIONAL METHOD | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2001-11-20 | — | — | US | claimed |
| EP-1149819-A1 | An improved process for acylation of naphthyl ethers | Council of Scientific and Industrial Research (IN) | 2001-10-31 | — | — | EP | claimed |
| EP-0656008-B1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS INC (US) | 2000-03-15 | — | — | EP | claimed |
| US-5866681-A | OLIGOPEPTIDES | COR THERAPEUTICS, INC. (US) | 1999-02-02 | — | — | US | claimed |
| JP-2675438-B2 | — | — | 1997-11-12 | — | — | JP | claimed |
| WO-1994003479-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1994-02-17 | — | — | WO | claimed |
| CN-117063121-A | Photosensitive film, photosensitive element, and method for producing laminate | 株式会社力森诺科 | 2023-11-14 | — | — | CN | disclosed |
| CN-113166043-A | Electrolyte for sulfur-based magnesium battery | 富士胶片和光纯药株式会社 | 2021-07-23 | — | — | CN | disclosed |
| CN-107447371-B | A kind of preparation method of high-strength temperature-resistant liquid crystal polymer spun-bonded non-woven fabrics | 中原工学院 | 2019-12-03 | — | — | CN | disclosed |
| CN-107447363-B | A kind of preparation method of the liquid crystal polymer melt spraying non-woven fabrics for high temperature filtration | 中原工学院 | 2019-11-29 | — | — | CN | disclosed |
| CN-108780924-A | Electrolyte containing magnesium ions | 富士胶片和光纯药株式会社 | 2018-11-09 | — | — | CN | disclosed |
| US-20180185325-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | THESAN PHARMACEUTICALS, INC. (US) | 2018-07-05 | — | — | US | disclosed |
| EP-0677519-A1 | CHROMAN DERIVATIVE AND MEDICINAL USE THEREOF | Japan Tobacco Inc. (JP) | 1995-10-18 | — | — | EP | disclosed |
| WO-1994003479-A1 | THROMBIN RECEPTOR ANTAGONISTS | COR THERAPEUTICS, INC. (US) | 1994-02-17 | — | — | WO | disclosed |
| US-4692550-A | Continuous process for thermal splitting of carbamic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1987-09-08 | — | — | US | disclosed |
| EP-0092738-B1 | PROCESS FOR THE CONTINUOUS THERMAL DECOMPOSITION OF CARBAMIC-ACID ESTERS | BAYER AG (DE) | 1985-07-24 | — | — | EP | disclosed |
| US-4526722-A | Manufacture of diacyloxy aromatic compounds | ASHLAND OIL, INC. (US) | 1985-07-02 | — | — | US | disclosed |
| EP-0092738-A1 | Process for the continuous thermal decomposition of carbamic-acid esters | BAYER AG (DE) | 1983-11-02 | — | — | EP | disclosed |
| US-4388246-A | THERMAL SPLITTING OF CARBAMATES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180185325-A1 | 12H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME | AHR, NR1H2, NR1H3 | HTR1B 213/4885KCNA3 3417/4885HTR1D 950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.